Improvement of revised international staging system risk stratification in patients with newly diagnosed multiple myeloma using a high bone marrow plasma cell percentage: a real-world study in China.

More importantly, the AUC exhibited an increasing trend over time, with predictive accuracy progressively improving from 0.681 at 12 months to 0.739 at 36 months ( Supplementary Figure 5 ). 3.5 Subgroup analysis In the subgroup analyses, the BMPC% was categorized into low, medium, and high, demonstrating a significant prognostic distinction across various patient demographics.

also in 63,971 other papers